Cholinergie agents arepotent modulators of insulin release that aet via musearinie reeeptors. We now investigated the musearlnie receptor subtype present in rat panereatic islets in binding and funetional studies. Binding of 5 nM The high-affinity Kds were 8.5, 56, 1300 and 1300 nM, respectively. The high affinity Kd of the muscarinie receptor agonist, arecaidine propargyl ester (APE), was 8.1 nM. The EC 50 for the biologieal effects of APE on insulin and glucagon secretion was 3.2 and 2.3 nM. The rank order for the high-affinity biological effects of antagonists (inhibition of APE-mediated insulin/ glucagon release) was almost the same as for binding. The data indicate that rat pancreatie islets contain neither an MI subtype (high-affinity for pirenzepine) nor an M 2 subtype (high-affinity for methoctramine) receptor. However, the data evidence an M 3 receptor subtype, since SiHC in the absence of the M 1 receptor subtype shows a relatively high affinity to the receptors in rat panereatie islets.
Introduction
The pancreatic islets of Langerhans are innervated by parasympathetic nervous fibres (Coupland, 1958) which are organized in a perlinsular plexus with direct innervation to the cells (Miller, 1981) . Cholinergic Stimulation of insulin release is thought to participate in the secretory response of the pancreatic B-cell to food intake, e.g. in the cephalic phase of insulin secretion (Malaisse, 1972) . The importance of cholinergic innervation for islet function is suggested by the 10-fold higher concentration of choline acetyltransferase in the islets versus that in the adjacent exocrine tissue (Godfrey and Matschinsky, 1975) . In vivo and in vitro administration of musearlnie agonists stimulates insulin secretion (Malaisse, 1972) . The stimulatory action of acetylcholine on the endocrine pancreas is abolished by atropine (Grill and Östenson, 1983; Kaneto and Kosaka, 1974; Holst et al., 1981; Honey and Weir, 1980) ; the IC 50 for .inhibition of acetylcholine-induced insulin release by the antagonist methylscopolamine is less than 0.4 nM (Grill and Östenson, 1983) . Binding studies with [ 3 H]N-methylscopo1amine (eHJNMS) (Malaisse et al., 1985) or [ 3 H]quinuclidinylbenzilate (Palafox et al., 1986) demonstrated the presence of muscarinic receptors in islets. The IC 50 of inhibition of [ 3 H]NMS binding in rat pancreatic islets was approximately 5 nM when unlabelled N-methylscopolamine was used (Östenson and Grill, 1985) .
At least three different muscarinic receptor subtypes have been proposed on the basis of different affinities for antagonists such as pirenzepine (Hammer and Giachetti, 1982) , methoctramine (Melchiorre, 1988; Melchiorre et al., 1987) , AF-DX 116 (Micheletti et al., 1987) and bexahydro-sila-difenidol as weil as sila-hexocyclium (SiHC; Lambrecht et al., 1988; Eltze et al., 1988; Waelbroeck et al., in press ). The subtypes have been termed M 1 (neuronal type), M 2 (M 2 a; cardiac type) and M 3 (M 2 p smooth musclejglandular type) receptors (for recent reviews see Mitchelson, 1988; Melchiorre, 1988; Mutschier et al., 1988) . Five receptor subtypes were identified by molecular cloning studies and were found to be the products of distinct genes. These subtypes were termed m1 to m5 (Bonner et al., 1987; Buckley et al., in press ). The antagonist binding properties of the individual cloned m1, m2 and m3 receptors and their pattems of expression in various tissues correspond closely to those of the pharmacologically defined M 1 , M 2 and M 3 receptors (Peralta et al., 1987; Akiba et al., 1988; Maeda et al., 1988; Buckley et al., in press ).
The limited selectivity of available ligands has long hampered receptor subtype characterization in pancreatic islets. The results of functional sturlies ruled out the presence of M 2 cardiac type receptors in mouse islets (Henquin and Nenquin, 1988) as weil as that of the M 1 subtype in rat endocrine pancreas (Otsuki et al., 1985) . In the present study an attempt was made to characterize the muscarinic receptor subtype in both functional and binding studies with rat islets of Langerhans. (Hammer et al., 1980} , methoctramine (M 2 > M 1 > M 3 ) (Melchiorre et al., 1987; Melchiorre, 1988) , and SiHC (M 1 > M 3 > M 2 ) Waelbroeck et al., 1989) were used for the purpose.
Materials and methods

Animals
Wistar rats of either sex, weighing between 180 and 250 g, were used. They were kept on a standard pellet diet (Altromin, LagejLippe, W.
Germany) and tap water ad libitum at 22 ° C with a 12-h lightjdark rhythm.
Drugs and chemieals
The following compounds were purchased or synthesized: atropine nitrate from Merck (Darmstadt, W. Germany), arecaidine propargyl ester (APE) (Mutschler and Hultzsch, 1973) and silahexocyclium (SiHC) (Tacke et al., 1989) 
Isolation of rat pancreatic islets
The procedure for isolation of pancreatic islets was the one described by Lacy and Kostianovsky (1967) with slight modifications as described earlier (Verspohl and Ammon, 1980) . Three rats were pretreated with 0.3 ml of 4% pilocarpine hydrochloride i.p. The animals were killed with ether after 3 h and the pancreases were isolated, minced, and washed twice with 20 ml ice-cold Hanks solution containing 3.7 mM glucose, 1 mgjml bacitracin, 0.2 mgjml SBTI and 0.2% albumin. Pancreas pieces were soaked and shaken in a water bath at 37 ° C in the presence of 650 U collagenasejg tissue suspension. After 15-18 min of incubation the tissue suspension was passed into 10 ml of ice-cold Hanks solution. The islets were separated by sedimentation and collected as described elsewhere (Lacy and Kostianovsky, 1967) . This method yields 300-500 isletsjrat pancreas. The islets were carefully selected in order to avoid contamination with exocrine tissue since the presence of musearlnie receptors on acini is weil known.
4. Binding experiments
After the islets were isolated, they were washed in ice-cold Hanks solution using centrifugation. Fifty islets were incubated in 0.3 ml Krebs-Ringer bicarbonate buffer plus 20 mM HEPES (KRBH) buffer, pH 7.4, containing 5 mg/ml bovine albumin, 1 mg/ml bacitracin and 0.1 mg/ml SBTI; 5 nM eH]NMS, with or without 100 ~tM unlabelled atropine, was then added. Binding experiments were performed in the presence of 16.7 mM glucose since elevated binding has been shown clearly with long-term high glucose concentrations or hyperglycemia (Östenson and Grill, 1985; . The incubation was terminated by cooling the samples ( 4 ° C), and the incubation mixtures were then filtered through glass microfibre filters (Whatman GF /C, U.K.) for 2 s under reduced pressure. The filters were then washed twice with 0.2 m1 ice-cold KRBH-buffer, which took less than 15 s. The dissociation experiment ai 4 ° C illustrated in fig. 1 (dotted line) showed that no major dissociation was to be expected during the washing procedure. The filters were suspended in the scintillation cocktail (toluene, ethylene glycol monomethylether and 2,5-diphenyloxazole), shaken vigorously and counted in a ß-scintillation spectrometer after luminescence bad disappeared.
To establish the apparent receptor affinity (dissociation constant, Kd) the competitive inhibition of specific [ 3 H]NMS binding by various concentrations of unlabelled antagonists was analyzed. This was done by fitting plots for bound drugs versus free drugs by means of a non-linear Ieastsquares computerprogram that analyzed the data in terms of one non-saturable and one or two saturable components (Dixon, 1974) .
Insulin and glucagon secretion
To measure insulin secretion, five islets were incubated for 60 min at 37 ° C in the aforementioned KRBH buffer after having been primed for 60 min with 16.7 mM glucose. Insulin and glucagon released into the medium by the islets was assayed with radioimmunoassay kits using rat insulin or glucagon as a standard. Each compound had been checked for non-interference with the insulin and glucagon radioimmunoassays. For statistical evaluation of whole curves, multiple comparisons of means were carried out by two-way analysis of variance (F-test). Dunnett's test was used thereafter if several conditions were to be compared to the control experiments. EC 50 s of biologic effects were determined by means of the RS/1 statistics pack (BBN Software Products Corp.).
Proteindetermination
The protein content was measured in extra batches within each binding experiment. The protein content of the solubilized pancreatic islets (solubilized with 0.1 N NaOH) was measured using bovine serum albumin as a standard (Bradford, 1976 ).
Results
Timecourse of [ 3 H]NMS binding
The binding of 5 nM [ 3 H]NMS to isolated rat islets at 37 ° C was half maximal after 30 min and maximal binding occurred at 60 min ( fig. 1 ). The velocity of binding was much lower than that shown earlier by Grill and Östenson (1983) and by Malaisse et al. (1985) . At 60 min, maximal binding was 1.29% of added radioactivity per 10 11-g islet protein.
N on-specific binding ( determined in the
• / nonspecific / "-9 9---------Q presence of 100 p.M atropine) ranged from 0.10 to 0.2690 of added radioactivity per 10 p.g islet protein. All subsequent binding studies were therefore carried out for 60 min. At 30 min, dissociation of labeled Iigand at 4 ° C was slow, i.e. the half life was more than 60 min. fig. 2) . Inhibition was essentially complete over four orders of magnitude (1-10000 nM). Binding analysis of the competition-inhibition curve revealed more than a single binding site with a Kd 1 of 8.06 nM and Kd 2 of 5840 nM (table 1) and a Capacity of Bmaxi = 36.8 and Bmax 2 = 91.9 fmol/10 p.g islet protein.
Muscarinic receptor agonist, APE
APE inhibited [ 3 H]NMS binding in a concentration-related manner (
In rat pancreatic islets, glucose alone (absence of muscarinic receptor agonist) increased insulin release ( fig. 3) . APE increased insulin release in a dose-dependent biphasic manner that was independent of the glucose concentration (3.0 mM = substimulatory and 16.7 mM = stimulatory). Glu- cose alone (absence of muscarinic receptor agonist) decreased glucagon release (fig. 4) . APE increased glucagon release in a dose-dependent biphasic mannerat both 3.0 and 16.7 mM glucose.
Muscarinic receptor antagonists
The concentration of unlabelled atropine causing half maximal inhibition of [ 3 H]NMS binding was ca. 30 nM (IC 50 ) (fig. 5 ). Binding analysis of the competition-inhibition curves generated with unlabelled antagonists revealed more than a single binding site with Hili coefficients of less than 0.6 in all cases. For atropine, e.g. Kd 1 was 8.46 ± 1.13
and Kd 2 was 463 ±54 nM, respectively. The rank order for inhibition of antagonist high-affinity binding was atropine > SiHC > pirenzepine = methoctramine (table 1) .
When islets were stimulated by 10 p.M APE in the presence of 16.7 mM glucose, muscarinic re-ceptor antagonists inhibited insulin release ( fig. 6 ). The rank order of potency was atropine = SiHC > pirenzepine > methoctramine (table 1) . No antagonist lowered insulin release below the values obtained with glu~ose alone (fig. 6) , and no antagonist antagonized the effect of glucose alone (data not shown).
In the presence of 3 mM glucose plus 10 p.M APE, muscarinic receptor antagonists inhibited glucagon release (fig. 7) . The rank order of potency was atropine > SiHC > pirenzepine = methoctramine (table 1) . Atropine, but not other antagonists lowered glucagon release below values obtained wi th glucose alone ( fig. 7) .
Discussion
Muscarinic receptor agonist
Our data clearly show that muscarinic binding sites are present on rat pancreatic islets. APE which is selective for muscanruc over nicotinic receptors inhibits [ 3 H]NMS binding and stimulates both insulin and glucagon release at similar concentrations in a biphasic, dose-dependent manner.
Muscarinic receptor antagonists
Since no agonists selective for muscarinic receptor subtypes are available, antagonist were now used to characterize the muscarinic receptor subtype in rat pancreatic islets. There was a clear rank order of affinity: the highest affinity was found for the compound, SiHC, which exhibits a similar affinity for M 1 and for M 3 receptors Waelbroeck et al., in press) . The low affinity of pirenzepine indicates that the M 1 subtype is not important and the low affinity of methoctramine indicates that M 2 receptor subtypes arenot predominant in rat pancreatic islets. The M 3 receptor subtype also appears tobe that most involved in A-cells. This receptor subtype had orlginally been named M 4 • Functional data reported by Henquin and Nenquin (1988) make it likely that this subtype is involved in islets effects.
lnitiating or modulating effect of a museartnie receptor agonist?
Ambient glucose stimulates insulin secretion and inhibits glucagon secretion (Verspohl and Ammon, 1987) . The musearlnie receptor agonist, APE, both initiates and modulates insulin release. The fact that, in cantrast to Herrnans et al. (1986) , we were able to show an initiating (absence of stimulatory glucose) insulinotropic effect of a musearlnie receptor agonist may have been due to species differences (mouse) or to the fact that our islets were prlmed by an 1-h preincubation in the presence of 16.7 mM glucose or been the result of using a highly specific agonist in contrast to other groups.
The musearlnie receptor agonist, APE, is able to modulate the glucose-mediated inhibition of glucagon release. Our data confirm those of Östensen and Grill (1985) by showing that musearlnie receptor antagonists inhibit the glucagon release stimulated by cholinergic substances.
The receptor subtype population cannot be decided from binding studies alone since rat pancreatie islets are a heterogenaus cell population which may obscure a receptor subtype on a cell type which is only present in low amounts. The functional data nevertheless indicate, first that the measured binding sites are related to the B and A cells of rat pancreatic islets and, second, that the musearlnie receptor agonist bad an insulinotropic and glucagonotropic effect independent of the glucose concentration used.
Extrapolation of the in vitro situation
These in vitro data will need further evaluation from in vivo experiments since atropine and possibly other antagonists have been claimed based on the in vivo experiments, to behave differently by not being selective. Atropine and pirenzepine not only do antagonize musearlnie effects but they also antagonize secretin and cholecystokinin-309 mediated effects (Otsuki et al., 1987; You and Chey, 1988) .
Taken together, our data are consistent with the opinion that rat pancreatic islets contain M 3 musearlnie subtypes as also does the exocrine pancreas (Louie and Owyang, 1985; Dehaye et al., 1983) . ldentifying selective M 3 agonist interacting with the endocrlne panereas but hopefully not with other glands would provide a valuable tool for the development of new insulinotropic drugs. In conciusion, the binding and functional data indicate the predominant presence of an M 3 receptor subtype in the rat pancreatic islets.
